Takeda Pharms Na Drug Patent Portfolio

Takeda Pharms Na owns 1 orange book drug protected by 2 US patents Given below is the list of Takeda Pharms Na's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7396841 Injections 17 Feb, 2022 Expired
US7396841 Injections 17 Aug, 2021 Expired


Given below is the list of recent legal activities going on the following drug patents of Takeda Pharms Na.

Activity Date Patent Number
Patent litigations
Expire Patent 05 Aug, 2016 US7396841
Post Issue Communication - Certificate of Correction 05 Feb, 2009 US7396841
Recordation of Patent Grant Mailed 08 Jul, 2008 US7396841
Patent Issue Date Used in PTA Calculation 08 Jul, 2008 US7396841
Issue Notification Mailed 18 Jun, 2008 US7396841
Dispatch to FDC 06 Jun, 2008 US7396841
Application Is Considered Ready for Issue 20 May, 2008 US7396841
Issue Fee Payment Verified 15 May, 2008 US7396841
Issue Fee Payment Received 15 May, 2008 US7396841
Mail Examiner's Amendment 19 Mar, 2008 US7396841
Mail Notice of Allowance 19 Mar, 2008 US7396841
Mail Examiner Interview Summary (PTOL - 413) 19 Mar, 2008 US7396841
Case Docketed to Examiner in GAU 12 Mar, 2008 US7396841
Notice of Allowance Data Verification Completed 12 Mar, 2008 US7396841
Interview Summary Record 10 Mar, 2008 US7396841


Takeda Pharms Na's Family Patents


Family Patents



Takeda Pharms Na Drug List

Given below is the complete list of Takeda Pharms Na's drugs and the patents protecting them.


1. Prevacid Iv

Prevacid Iv is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7396841
(Pediatric)
Injections 17 Feb, 2022
(2 years ago)
Expired
US7396841 Injections 17 Aug, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prevacid Iv's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List